Morphine Sulfate Injection
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Yes — there is an active recall. 7 ongoing FDA recalls mention Morphine (189 total). Check the affected lots below.
Most common reason: Sterility / contamination (135 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Morphine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Failed Dissolution Specifications
Failed Impurities/Degradation Specification
Failed Impurities/Degradation Specification
The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.
Subpotent Drug
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Lack of sterility assurance
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.
Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Labeling: Missing Label
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Defective container: Cracked vials leading to lack of sterility assurance
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.